K Pharma,Inc.

4896

JP3280900006

Pharmaceuticals

Delayed Japan Exchange Other stock markets 06:40:48 04/07/2024 BST			5-day change	1st Jan Change
729 ^JPY	-0.41%		-5.94%	+1.25%

04-13	Certain Common Stock of K Pharma,Inc. are subject to a Lock-Up Agreement Ending on 13-APR-2024.	CI
2023	K Pharma,Inc. has completed an IPO in the amount of ¥1.596 billion.	CI

K Pharma,Inc. has filed an IPO.

September 12, 2023 at 05:00 am

K Pharma,Inc. has filed an IPO.

Security Name: Common Stock
Security Type: Common Stock
Securities Offered: 1,680,000

Transaction Features: Sponsor Backed Offering

Latest news about K Pharma,Inc.

Certain Common Stock of K Pharma,Inc. are subject to a Lock-Up Agreement Ending on 13-APR-2024.	04-12	CI
K Pharma,Inc. has completed an IPO in the amount of ¥1.596 billion.	17/10/23	CI
K Pharma,Inc. has filed an IPO.	12/09/23	CI

K Pharma Inc is a Japan-based company mainly engaged in the pharmaceutical business. The Company operates through a single segment of research, development, manufacture, and sale of pharmaceuticals, among others. The Company is engaged in induced pluripotent stem cell (iPS) drug discovery business. Neural progenitor cells, the cells that form the basis of nerves, are created from iPS cells, cryopreserved, and then 200000 cells are transplanted by injection into the site of a patient's spinal cord injury. The Company is also engaged in the research, development, manufacture and sale of regenerative medicine products.

Sector

Pharmaceuticals

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
K PHARMA,INC.	+1.25%	52.62M
ELI LILLY AND COMPANY	+54.07%	809B
NOVO NORDISK A/S	+38.59%	621B
JOHNSON & JOHNSON	-7.05%	351B
MERCK & CO., INC.	+15.44%	319B
ABBVIE INC.	+5.72%	289B
ASTRAZENECA PLC	+13.40%	238B
ROCHE HOLDING AG	+0.61%	221B
NOVARTIS AG	+13.24%	218B
AMGEN INC.	+7.42%	166B

Other Pharmaceuticals

K Pharma,Inc.

Equities

4896

JP3280900006

Pharmaceuticals

K Pharma,Inc. has filed an IPO.

Latest news about K Pharma,Inc.

Chart K Pharma,Inc.

Company Profile

Sector Other Pharmaceuticals